AKT inhibitor VIII (AKTI-1/2)
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | AKT inhibitor VIII is a cell-permeable and reversible quinoxaline compound that potently and selectively inhibits Akt1/Akt2 activity (IC50 = 58 nM, 210 nM, and 2.12 μM for Akt1, Akt2, and Akt3, respectively, in in vitro kinase assays). | ||
---|---|---|---|
Targets |
|
Catalog Num | A11286 |
---|---|
Formula | C34H29N7O |
Molecular Weight | 551.6 |
CAS Number | 612847-09-3 |
SMILES | C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=NC6=CC7=C(C=C6N=C5C8=CC=CC=C8)N=CN7 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro | DMSO | 19 mg/mL (34.44 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 18.13 mL | 90.65 mL | 181.29 mL |
0.5 mM | 3.63 mL | 18.13 mL | 36.26 mL |
1 mM | 1.81 mL | 9.06 mL | 18.13 mL |
5 mM | 0.36 mL | 1.81 mL | 3.63 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2